Stock KH6 NEWAMSTERDAM PHARMA COMPANY N.V.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar NewAmsterdam Pharma Company N.V. Börse Stuttgart

Equities

KH6

NL00150012L7

Market Closed - Börse Stuttgart
Other stock markets
 10:14:14 2024-06-28 am EDT 		5-day change 1st Jan Change
17.9 EUR +0.56% Intraday chart for NewAmsterdam Pharma Company N.V. +6.55% +80.81%
Jun. 11 NewAmsterdam Pharma Gets Another US Patent Extending IP Protection for Obicetrapib Until July 2043 MT
Jun. 10 Transcript : NewAmsterdam Pharma Company N.V. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 10:40 AM

Chart calendar NewAmsterdam Pharma Company N.V.

bdd071c776ebfb0178.8W0XqW4BXgywXWwCLOTP5jLxKO1aHR_-TprEge1jR5E.oQNWwV5WCELdNF5RGZyO03O7eJkfVX6cKKmcxKw5CNicJXvEIHknQIUvBw~fe3ca59743555936daedfdc5ad42c34c

Upcoming events on NewAmsterdam Pharma Company N.V.

2024-08-04 Q2 2024 Earnings Release (Projected)
2024-11-10 Q3 2024 Earnings Release (Projected)
2025-03-27 Q4 2024 Earnings Release (Projected)
2025-05-06 Q1 2025 Earnings Release (Projected)

Past events on NewAmsterdam Pharma Company N.V.

2024-06-10 10:40 am Goldman Sachs Global Healthcare Conference
2024-06-05 06:00 pm Annual General Meeting
2024-06-05 03:00 pm Jefferies Global Healthcare Conference
2024-06-01 02:05 pm National Lipid Association Scientific Conference - Abstract Number: 141
2024-05-31 05:30 pm National Lipid Association Scientific Conference - Abstract Number: 139
2024-05-31 05:30 pm National Lipid Association Scientific Conference - Abstract Number: 140
2024-05-31 05:30 pm National Lipid Association Scientific Conference - Abstract Number: 127
2024-05-31 05:30 pm National Lipid Association Scientific Conference - Abstract Number: 138
2024-05-31 05:30 pm National Lipid Association Scientific Conference - Abstract Number: 128
2024-05-28 09:24 am European Atherosclerosis Society Congress
2024-05-28 09:17 am European Atherosclerosis Society Congress - Session Name: 0660
2024-05-28 08:12 am European Atherosclerosis Society Congress - Session Name: 0601
2024-05-27 08:42 am European Atherosclerosis Society Congress - Session Name: 0390
2024-05-16 09:00 am R&D Day - Key Opinion Leader
2024-05-14 04:35 pm RBC Capital Markets Global Healthcare Conference
2024-05-09 08:00 am Q1 2024 Earnings Release
2024-04-07 01:15 pm American College of Cardiology Scientific Meeting
2024-03-11 Jefferies Biotech on the Bay Summit
2024-03-11 04:00 pm Leerink Partners Global Biopharma Conference
2024-03-04 02:10 pm TD Cowen Health Care Conference

Annual results

Fiscal PeriodDecember 2021 2022 2023 2024
Net sales
Million EUR		Released
Forecast
Spread 		0,00


97,5
98,2
-0.69%		13,0
14,2
-8.63%
8,64

EBITDA
Released
Forecast
Spread 		0,00


0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million EUR		Released
Forecast
Spread 		0,00


-6,96
7,11
-197.91%		-169
-172
2.01%
-187

Earnings before Tax (EBT)
Million EUR		Released
Forecast
Spread 		0,00


-78,1
7,00
-1215.03%		-163
-169
3.52%
-207

Net income
Million EUR		Released
Forecast
Spread 		-28,6


-78,1
7,00
-1215.03%		-163
-167
2.45%
-210

EPS
EUR		Released
Forecast
Spread 		-2,53


-0,96
0,08
-1300%		-1,98
-2,03
2.24%
-2,34

Announcement Date04/08/2231/03/2328/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q3 2022 Q4 2022 S2 2023 Q1 2023 Q2 2023 S1 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million EUR		Released
Forecast
Spread
3,50


1,75

4,00
7,20
-44.44%
1,47


1,95

9,56



1,77

1,30
1,61
-18.88%
1,11


1,84


4,56


0,00


0,00

EBITDA
Million EUR		Released
Forecast
Spread









27,6


29,0

























EBIT
Million EUR		Released
Forecast
Spread
-25,5


-25,8





-34,2


-36,7





-48,0

-51,6
-46,7
-10.55%
-50,5


-45,8


-39,6


-41,9


-37,3

Earnings before Tax (EBT)
Million EUR		Released
Forecast
Spread



-39,3





-33,7


-37,5





-48,2

-93,8
-36,2
-158.85%
-47,6


-42,0


-37,2


-38,5


-33,9

Net income
Million EUR		Released
Forecast
Spread



-39,2





-33,7


-36,1

-75,1



-46,9

-93,8
-43,6
-115.03%
-48,3


-42,3


-37,7


-38,5


-33,9

EPS
EUR		Released
Forecast
Spread



-0,45





-0,41


-0,43

-0,92



-0,56

-0,99
-0,49
-101.98%
-0,54


-0,47


-0,42


-0,40


-0,35

Announcement Date--31/03/23--07/08/23-08/05/24-----

Upcoming sector events for NewAmsterdam Pharma Company N.V.

2024-07-23 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-24 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-25 01:00 am ARGENX SE: Q2 2024 Earnings Release
2024-07-29 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for NewAmsterdam Pharma Company N.V.

2024-06-05 03:51 am PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release
2024-05-17 07:00 am AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
2024-05-16 07:46 am BIOCON LIMITED: Q4 2024 Earnings Release
2024-05-16 01:00 am ZEALAND PHARMA A/S: Q1 2024 Earnings Release
2024-05-15 LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release
2024-05-15 08:05 am THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
2024-05-15 07:00 am CABALETTA BIO, INC.: Q1 2024 Earnings Release
2024-05-14 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
2024-05-14 04:05 pm ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14 04:00 pm ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. NAMS Stock
  4. KH6 Stock
  5. Calendar NewAmsterdam Pharma Company N.V.